CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $62,000 | -86.8% | 22,500 | -85.0% | 0.02% | -83.9% |
| Q3 2016 | $470,000 | -77.1% | 150,000 | -62.5% | 0.16% | -75.9% |
| Q2 2016 | $2,048,000 | -0.9% | 400,000 | -20.9% | 0.64% | +14.6% |
| Q1 2016 | $2,067,000 | -64.0% | 505,420 | -28.7% | 0.56% | -52.9% |
| Q4 2015 | $5,749,000 | -1.7% | 708,888 | +2.3% | 1.19% | +0.5% |
| Q3 2015 | $5,850,000 | +23.5% | 693,122 | +37.7% | 1.18% | +36.6% |
| Q2 2015 | $4,735,000 | +73.1% | 503,222 | +70.4% | 0.87% | +76.0% |
| Q1 2015 | $2,735,000 | +224.1% | 295,354 | +223.6% | 0.49% | +392.0% |
| Q4 2014 | $844,000 | -34.1% | 91,274 | -36.3% | 0.10% | +29.9% |
| Q3 2014 | $1,280,000 | +13.6% | 143,303 | -0.2% | 0.08% | +54.0% |
| Q2 2014 | $1,127,000 | +76.1% | 143,523 | +77.3% | 0.05% | +194.1% |
| Q1 2014 | $640,000 | – | 80,950 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,241,550 | $7,520,000 | 4.03% |
| Tamarack Advisers, LP | 1,875,000 | $4,350,000 | 2.07% |
| CLOUGH CAPITAL PARTNERS L P | 2,075,663 | $4,816,000 | 0.46% |
| Rock Springs Capital Management LP | 1,200,000 | $2,784,000 | 0.12% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,192,034 | $9,726,000 | 0.08% |
| PUTNAM INVESTMENTS LLC | 3,092,133 | $7,174,000 | 0.02% |
| Renaissance Technologies | 528,913 | $1,227,000 | 0.00% |
| SCOTIA CAPITAL INC. | 19,120 | $44,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 51,200 | $118,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 700 | $2,000 | 0.00% |